FDA to Use Rosetta s Resolver System for Data Submission Analysis | GenomeWeb

NEW YORK, Aug. 24 (GenomeWeb News) - The US Food and Drug Administration will use Rosetta Biosoftware's Rosetta Resolver system for genomic data management and analysis in order to analyze microarray data from sponsors, Rosetta said today.

According to Rosetta, the Center for Drug Evaluation and Research, an arm of the FDA, will use the system when evaluating genomic data submitted through the voluntary genomic data submissions program the agency initiated this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.